Meeting the Moment: How the Opioid Crisis Has Changed the Way We Study, Evaluate and Treat Patients (Session 1)
This is a three-part information series presented by the University of Virginia Department of Anesthesiology and the Office of Pain Management and Opioid Stewardship:
- Session 1: September 13 (see below for description)
- Session 2: November 1
- Session 3: December 6
For more information, view the 2022 UVA Anesthesiology Pain Series Flyer.
Session 1a: Who We Are, What We Do, Where We Are Headed (7:30-8pm)
We hope you can sign on early at 7:30 to hear about the Department of Anesthesiology’s establishment of the Office of Pain Management and Opioid Stewardship, and the Perioperative Pain Center. This is a commitment at UVA to bring its resources and brainpower to bear in the fight against opioid misuses. These initiatives have a unified vision and complementary missions. In 2021, more than 107,000 people died from illicit and prescription opioids in the US [AMA Issue brief 5/12/22]. As UVA alumni, we welcome your participation in this series and your involvement in our opioid stewardship project. We must meet the moment together.
Session 1b: Practice Strategies: Our Commitment to Healthcare Providers and Patients (8-9pm: 1 CME Credit)
In this first program of our series, we will explore practical methods to make an impact in treating patients with pain. We will look at Opioid Use Disorder (OUD) and how it impacts practice. We will explain how to establish an opioid agreement with emphasis on patient and practitioner responsibilities. Strategies such as use of naloxone and Buprenorphine will be addressed. We will also address warning signs for practitioners and colleagues as burnout and stress – mindful of the toll that the pandemic and opioid crisis have taken on healthcare providers.
Our Spotlight talk is from Lynn Kohan, MD, UVA professor of anesthesiology and pain medicine. She is the division head, medical director of UVA’s Pain Management Center as well as the director for the pain fellowship program at UVA. This year, Dr. Kohan spearheaded the establishment of national Buprenorphine prescribing recommendations and she will review this work.